Effect of disease-specific complications on the prediction of utilities in Parkinson's disease

被引：0
|
作者：
Siebert, U
Bornschein, B
Spottke, EA
Dodel, R
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Univ Munich, Munich, Germany
[3] Univ Bonn, D-5300 Bonn, Germany
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66128-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：794 / 794
页数：1
相关论文
共 50 条
  • [41] Understanding complications of Parkinson's disease
    Stoessl, AJ
    MOVEMENT DISORDERS, 2002, 17 : S6 - S7
  • [42] Disease-specific or co-morbid factors - Which has the greatest impact on disability in Parkinson's disease?
    Shulman, L. M.
    Anderson, K. E.
    Gruber-Baldini, A. L.
    Reich, S. G.
    Fishman, P. S.
    Weiner, W. J.
    MOVEMENT DISORDERS, 2006, 21 : S509 - S509
  • [43] Disease-specific training in Parkinson's disease for care assistants: a comparison of interactive and self-study methods
    Axelrod, Lesley
    Bryan, Karen
    Gage, Heather
    Kaye, Julie
    Ting, Sharlene
    Williams, Peter
    Trend, Patrick
    Wade, Derick
    CLINICAL REHABILITATION, 2012, 26 (06) : 545 - 557
  • [44] Patients are doing it for themselves: A survey on disease-specific knowledge acquisition among people with Parkinson's disease in Sweden
    Riggare, Sara
    Hoglund, Par J.
    Forsberg, Helena Hvitfeldt
    Eftimovska, Elena
    Svenningsson, Per
    Hagglund, Maria
    HEALTH INFORMATICS JOURNAL, 2019, 25 (01) : 91 - 105
  • [45] Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot study
    Boerger, Matthias
    Funke, Sebastian
    Leha, Andreas
    Roser, Anna-Elisa
    Wuestemann, Ann-Katrin
    Maass, Fabian
    Bahr, Mathias
    Grus, Franz
    Lingor, Paul
    PARKINSONISM & RELATED DISORDERS, 2019, 63 : 3 - 9
  • [46] Analysis of metabolic dynamics under the pathology of Parkinson's disease by analyzing human disease-specific iPS cells
    Suda, Yukari
    Kuzumaki, Naoko
    Iwasawa, Chizuru
    Matsuo, Miri
    Narita, Michiko
    Ikegami, Daigo
    Suematsu, Makoto
    Hattori, Nobutaka
    Okano, Hideyuki
    Narita, Minoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S93 - S93
  • [47] Comorbidity burden in systemic sclerosis: beyond disease-specific complications
    Pagkopoulou, Eleni
    Arvanitaki, Alexandra
    Daoussis, Dimitrios
    Garyfallos, Alexandros
    Kitas, George
    Dimitroulas, Theodoros
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (09) : 1507 - 1517
  • [48] Comorbidity burden in systemic sclerosis: beyond disease-specific complications
    Eleni Pagkopoulou
    Alexandra Arvanitaki
    Dimitrios Daoussis
    Alexandros Garyfallos
    George Kitas
    Theodoros Dimitroulas
    Rheumatology International, 2019, 39 : 1507 - 1517
  • [49] Longitudinal intronic RNA-Seq analysis of Parkinson's disease patients reveals disease-specific nascent transcription
    Koks, Sulev
    Pfaff, Abigail L.
    Bubb, Vivien J.
    Quinn, John P.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (11) : 945 - 957
  • [50] Developing A Novel Disease-Specific Psychosis Severity Scale in Parkinson's disease (Psy-PD): A Pilot Study
    Wan, Y. M.
    Tan, E. K.
    Aarsland, D.
    Lee, T. S.
    Lo, Y. L.
    Ting, S. K. S.
    Martinez-Martin, P.
    Chaudhuri, K. R.
    MOVEMENT DISORDERS, 2020, 35 : S585 - S585
12345